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Objective: Articular cartilage of the mandibular condyle has limited ability to regenerate itself after injury.
This study was to investigate whether osteochondral defects in mandibular condyle could be repaired by
NELL-1(NEL-like molecule-1)-modiﬁed autogenous bone marrow mesenchymal stem cells (BMMSCs)
and poly lactic-co-glycolic acid (PLGA) composite.
Methods: Osteochondral defects of 3 mm-diameter 5 mm-depth were created unilaterally in the central
part of the condyle in 50 adult goats. The injury sites were treated with NELL-1-modiﬁed BMMSCs/PLGA,
BMMSCs/PLGA, PLGA alone, or left empty. The defect area was monitored using gross examination,
histology, immunohistochemistry, and micro-computed tomography (m-CT). Implanted BMMSCs were
tracked using Adeno-LacZ labeling.
Results: The NELL-1-modiﬁed BMMSCs/PLGA group showed vigorous and rapid repair leading to
regeneration of ﬁbrocartilage at 6 weeks and to complete repair of native articular cartilage and sub-
chondral bone at 24 weeks. The BMMSCs/PLGA group also completely repaired the defect with ﬁbro-
cartilage at 24 weeks, but the cartilage in the BMMSCs/PLGA group was less well-organized than the
NELL-1-modiﬁed BMMSCs/PLGA. The osteochondral defects in the PLGA and empty defect groups were
poorly repaired, and no cartilage in the empty defect group or only small portion of cartilage in the PLGA
group was found. In vivo viability of implanted cells was demonstrated by the retention for 6 weeks in
the defects.
Conclusion: These ﬁndings demonstrated that NELL-1-modiﬁed BMMSCs/PLGA composite can rapidly
repair large osteochondral defect in the mandibular condyle with regeneration of native ﬁbrocartilage
and subchondral bone.
 2011 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Due to the avascular nature and limitation in cell movement,
articular cartilage of the mandibular condyle has limited ability to
regenerate itself after injury1e3. Although various methods have
been developed for the treatment of articular cartilage lesions in
the mandibular condyle, few of them yield satisfactory results4e6.
Tissue engineering principles that combined living cells with
scaffolds are promising techniques for osteochondral defect repair
and have been studied in a variety of animal models7,8.J. Hu, State Key Laboratory of
l Surgery, West China College
hina. Tel: 86-028-85502334;
s Research Society International. PBone marrow mesenchymal stem cells (BMMSCs) have been
considered as promising candidates in the ﬁeld of bone and carti-
lage regeneration because of their rapid proliferation abilities,
multiple differentiation potential, and easy harvest9e11. However, in
many cases of tissue engineering applications, cell differentiation
toward a speciﬁc phenotype is highly desirable. Local administra-
tion of growth factors that can enhance cartilage healing is
a potentially powerful alternative approach to cartilage repair.
NELL-1 (NEL-like molecule-1) is a secretary molecule containing
a signal peptide sequence, an NH2-terminal thrombospondin (TSP)-
like module, ﬁve von Willebrand factor C domains, and six
epidermal growth factor-like domains and expresses preferentially
in cells of neural crest origin residing within the craniofacial
complex and central nervous system12e14. It is a novel growth
factor believed to speciﬁcally target cells committed to the osteo-
chondral lineage. Previous studies had shown its ability to stimu-
late secondary cartilage and bone formation in a rat palatal sutureublished by Elsevier Ltd. All rights reserved.
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NELL-1 can also promote chondrocytes proliferation and deposition
of cartilage-speciﬁc extracellular matrix materials in vitro14. These
ﬁndings suggest potential therapeutic beneﬁts of NELL-1 in the
stem cell-based repair of osteochondral defect.
In the current study, we adopted autologous BMMSCs as
a vector for control release of NELL-1 which is a differentiation
factor used to induce the differentiation of BMMSCs into
chondrocytes. Then, we prepared NELL-1-modiﬁed BMMSCs/Poly
lactic-co-glycolic acid (PLGA) scaffold composite in vitro and aimed
to explore the ability of NELL-1-modiﬁed BMMSCs/PLGA scaffold
composite to repair large osteochondral defect in goat mandibular
condyle.Materials and methods
Scaffold fabrication
PLGA (LA:GA¼ 75:25 wt%, Mw: 120,000) copolymer was
synthesized using a conventional method. PLGA scaffolds were
fabricated by using a salt leaching method using a mixture ratio of
1:15 (Polymer:Salt). Brieﬂy, 5 wt% PLGA solution was prepared by
dissolving it in chloroform and then mixed with sodium chloride.
The average pore diameter in the PLGA scaffold is
102.75 32.37 mm. A Teﬂon mold (Ø 3 5 mm:3 mm in diameter
and 5 mm in height) was then ﬁlled with the polymer/salt paste.
The paste was subsequently removed from the mold and placed in
distilled water for 2 days. Finally, samples were lyophilized for
several days and examined under scanning electron microscope
(S.E.M.) [Fig. 1(A)].Fig. 1. (A) S.E.M. photographs of produced PLGA scaffold without cells. (B) The seeded BMM
mandibular condyle. (D) Implantation of BMMSCs/PLGA composite in the defect. Bars¼ 1 mCell culture and transfection
Autologous BMMSCs were obtained from the left iliac crest of all
goats. The cells were isolated by density gradient centrifugation,
then suspended in alpha-minimum essential medium with 10%
fetal bovine serum (Gibco BRL, Gaithersburg, MD, USA) and
100 mg/ml penicillinestreptomycin (Gibco BRL, Gaithersburg, MD,
USA), and incubated at 37C with 5% humid CO2. Cells reached 90%
conﬂuencewere suspended for passage. Cells of passage three were
used for the gene transfection in vitro and transplantation in vivo.
Adenoviruses containing human rhNELL-1 (Ad-NELL-1) or
control b-galactosidase (Ad-LacZ) were constructed by Vector Gene
Technology Company Ltd., China. When BMMSCs were grown to
80% conﬂuence, they were transfected with Ad-NELL-1/LacZ. After
that, 10 ml of fresh culture mediumwas added to the cells and then
subjected to 48 h incubation. On the third day, the infected cells
were collected and seeded into PLGA scaffolds.Preparation of Cell/PLGA scaffold composite
Fibrin glue (TISSEEL kit, Baxter AG, Vienna, Austria) was used as
cell-loading carrier. BMMSCs or NELL-modiﬁed BMMSCs were
collected and resuspended in thrombin solution. Forty microliters
of thrombin solution containing 3106 cells was seeded into
a PLGA scaffold disc by micropipette. The scaffold was held with
sterile forceps and turned upside-down several times during the
seeding process so that the cells could be distributed throughout
the scaffold. A 30-mL TISSEEL solution (500 IU thrombin/ml) was
then added for ﬁbrin gel formation in the scaffold. After seeding,
the cell-scaffold constructs were kept in complete Dulbecco’sSCs attached on the PLGA scaffold. (C) Critical-size osteochondral defect created in the
m in A and 50 mm in B.
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implantation use [Fig. 1(B)]. For the PLGA group, the same volume
ﬁbrinogen and thrombin solutions without cells were seeded in
PLGA scaffolds.
Surgical protocol
Adult male Eastern Cross goats (weighing 32e37 kg, ages 25e28
months; n¼ 50) were used in this study. The Institutional Animal
Care and Use Committee approved all procedures used.
With the animals under general anesthesia, the left temporo-
mandibular joint (TMJ) was exposed via a 3-cm pre-auricular skin
incision. By lateral translation of the mandible, the condylar surface
was exposed. Then an osteochondral defect, 3 mm in diameter and
5 mm in depth, was created in the central part of the condyle with
a 3 mm diameter drill [Fig. 1(C)]. The articular disc was left intact.
The PLGA scaffold with NELL-1-modiﬁed BMMSCs (n¼ 12) or
BMMSCs (n¼ 12) was pressed ﬁt into the defect [Fig. 1(D)]. In the
PLGA group (n¼ 12), the defects were treated with cell-free PLGA
scaffolds. No treatment was made in the empty defect group
(n¼ 12). The contralateral joint remained intact as normal controls.
Gross morphology, histology and immunohistochemistry
Six goats in each group were sacriﬁced at 6 and 24 weeks post-
operatively, respectively. Themandibular condyles were excised for
gross examination and micro-computed tomography (m-CT) exam-
ination. After that all samples were ﬁxed in 4% formalin, decalciﬁed
in 30% formic acid, then embedded inparafﬁnand sectioned at 6-mm
thickness. Sections were stained with Safranin-O. The specimens
were graded blindly using a modiﬁed grading scale (Table I) from
a previous study15. To detect expression of type II collagen, immu-
nohistochemical evaluationwas performed using the avidinebiotin
immunoperoxidase method with an antibody raised against type II
collagen (Santa Cruz Biotechnology, Inc. CA, USA).Table I
Histological grading scale
Category Score
Safranin-O staining of the matrix
Normal 4
Slight increase or decrease 3
Moderate increase or decrease 2
Severe increase or decrease 1
None 0
Surface regularity
Smooth and intact 3
Slight irregularity 2
Moderate irregularity 1
Severe irregularity and disruption 0
Structure integrity
Normal 3
Slight disruption 2
Moderate disruption 1
Severe disruption 0
Bonding to the adjacent cartilage
Bonded completely 2
Bonded partially 1
Not bonded 0
Cartilage thickness, %(Compared with adjacent normal
cartilage thickness)
Normal 4
Slight increase or decrease 3
Moderate increase or decrease 2
Severe increase or decrease 1
None 0m-CT examination
The mandibular condyles obtained at 6 and 24 weeks were
evaluated with a m-CT 80 scanner (Scanco Medical, Bassersdorf,
Switzerland) for analysis of new bone formation within defects
before histology examination. The systemwas set to 70 kV, 114 mA,
500 ms integration time. Two ﬁxed, global thresholdswere applied:
an upper threshold that excluded the highly attenuating PLGA
particles from the analysis, and a lower threshold that excluded
unmineralized or poorly mineralized tissue from the analysis. The
volume of interest (VOI) was a ﬁxed cylinder of 5 mm in diameter
and 7 mm in height encompassing the entire scanned volume of the
defect. Bone volume to total volume ratio (BV/TV), indicating the
portion of mineralized tissue, was calculated for comparison.
In vivo tracing of implanted cells
LacZ-BMMSCs/PLGA composite was implanted in two additional
goats for in vivo tracing of implanted BMMSCs. The animals were
sacriﬁced at 6 weeks postoperatively and the mandibular condyles
were harvested and ﬁxed in 4% formalin overnight. Following that,
the condyle was stained in X-gal (5-bromo-4-chloro-3-indolyl-b-D-
galactopyranoside) substrate 1 mg/ml, 1 mmol/L MgCl2, 10 mmol/L
K4Fe(CN)6, and 10 mmol/L K3Fe(CN)6 in phosphate buffered saline
(PBS) for 24 h. After X-gal staining, the samples were placed in 4%
formalin again for complete ﬁxation, and then the samples were
decalciﬁed and embedded in parafﬁn and sectioned in a sagittal
plane. The sections were counterstained with Safranin-O.
Statistical analysis
All data were represented as means 95% conﬁdence intervals
(CI). Statistical signiﬁcance of differences among means was deter-
mined by analysis of variance (ANOVA) with post hoc comparison of
more than twomeans by the Bonferronimethod (SPSS Inc., Chicago,
IL, USA). A signiﬁcance level of 0.05 was used for all analyses.
Results
Gross examination
At 6 weeks after transplantation, the defects in both NELL-
1-modiﬁed BMMSCs/PLGA [Fig. 2(A)] and BMMSCs/PLGA [Fig. 2(B)]
groups were ﬁlled with shiny, white, translucent tissue with
sharply deﬁned margins, although the surface of the defects in the
BMMSCs/PLGA groups remained concave. The defects of the PLGA
group [Fig. 2(C)] showed red, irregular surface with depression. In
the empty defect group [Fig. 2(D)], the defects were ﬁlled with
brown, opaque tissue with a concavity toward the center.
At 24 weeks after transplantation, the injury sites seeded with
the NELL-1-modiﬁed BMMSCs/PLGA [Fig. 2(E)] and BMMSCs/PLGA
[Fig. 2(F)] showed smooth, ﬂush, and transparent cartilage. There
was little depression in the defect and the margin with normal
cartilage was indistinct. In the PLGA group [Fig. 2(G)], the defects
showed an irregular surface with ﬁrm cartilage-like tissues of
similar color to the surrounding cartilage. In the empty defect
group [Fig. 2(H)], arthritic changes were evident and defects
remained depressed and covered with ﬁbrous tissue.
Histology and immunohistochemistry
At 6 weeks after transplantation, the repair tissue in the
NELL-1-modiﬁed BMMSCs/PLGA [Fig. 3(A and E)] defect showed
a well-repaired cartilage with a relatively smooth surface without
depression, but thenewcartilagewas thickerand thecell arrangement
Fig. 2. Gross appearance of specimens. At 6 weeks, the defects in both NELL-1-modiﬁed BMMSCs/PLGA (A) and BMMSCs/PLGA (B) groups were ﬁlled with shiny, white, semi-
transparent tissue, but the surface of the defects in the BMMSCs/PLGA-treated groups remained concave. The PLGAgroup (C)was roughwith depression. In the empty defect group (D),
the defects were ﬁlled with opaque tissue with a deep concavity. At 24 weeks, the defects in the NELL-1-modiﬁed BMMSCs/PLGA (E) and BMMSCs/PLGA (F) groups were substituted
with smooth and translucent tissue just like host cartilage. In the PLGAgroup, the defects showed an irregular surfacewith ﬁrm cartilage-like tissues of similar color to the surrounding
cartilage (G). In the empty defect group, arthritic changes were evident and defects remained depressed (H). Arrows showed the defect created in the mandibular condyle.
Fig. 3. Histological photomicrographs of specimens 6 (AeH) and 24 (IeP) weeks after operation (Safranin-O staining). At 6 weeks, ﬁbrocartilage was regenerated completely in the
NELL-1-modiﬁed BMMSCs/PLGA group, but was thicker and more cellular than normal (A and E). Partial cartilage regeneration was observed in the BMMSCs/PLGA group (B and F,
arrows in F showed cartilage disruption). In the PLGA group, the defects were ﬁlled with concave ﬁbrous tissues containing small bone islands (C and G, arrows in G showed ﬁbrous
tissues in the defect). In the empty defect group the surgical sites contained ﬁbrous tissue (D and H). At 24 weeks, a layer of well-organized ﬁbrocartilage covering the subchondral
bone was observed in the NELL-1-modiﬁed BMMSCs/PLGA group (I and M); however, the regenerated cartilage in the BMMSCs/PLGA had incomplete integration (J and N, arrow in
N showed incomplete integration of cartilage). The PLGA group showed small portions of cartilaginous tissue formed adjacent to host cartilage with an irregular surface (K and O,
arrows in O showed cartilaginous tissue formed adjacent to host cartilage). The empty defect group showed non-cartilaginous structure and was almost ﬁlled with ﬁbrous tissue
and inﬂammatory changes (L and P). Bars¼ 500 mm in AeD and IeL, and 100 mm in EeH and MeP.
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Fig. 4. Histological scores of three groups at 6 and 24 weeks after operation (n¼ 6). The data shown are the means 95% CI.
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BMMSCs/PLGA group [Fig. 3(B and F)], large pieces of cartilage tissue
appeared onportions of the defects near the surface, although cellular
orientation in the neocartilage was disorganized. In the PLGA group
[Fig. 3(C and G)], the defects were ﬁlled with concave ﬁbrous tissues
containing small bone islands and no cartilage was observed. In some
of the samples some ﬁssure or defects in the repaired tissue were
observed. In the empty defect group [Fig. 3(D andH)] the surgical sites
contained ﬁbrous tissue and inﬂammatory changes.
At 24 weeks postoperatively, the cartilage repair of NELL-
1-modiﬁed BMMSCs/PLGA group [Fig. 3(I andM)] demonstrated the
thickness comparable to the normal one. The cell arrangement in
the newly formed cartilage showed the typical characteristics of
ﬁbrocartilage. The newly formed cartilage in the BMMSCs/PLGA
group was irregular and the surface was not as smooth as in the
NELL-1-modiﬁed BMMSCs/PLGA group [Fig. 3(J and N)]. The PLGAFig. 5. Immunostaining for type II collagen in the NELL-1-modiﬁed BMMSCs/PLGA (A and C)
group had more intense type II collagen staining compared with the BMMSCs/PLGA groupgroup [Fig. 3(K andO)] showed small portions of cartilaginous tissue
formed adjacent to host cartilage, and the defect surface was not
completely ﬁlled. Empty defect group showed non-cartilaginous
structure and was almost ﬁlled with ﬁbrous tissue [Fig. 3(L and P)].
Histological grading scores are presented in Fig. 4. Within the
corresponding time points, the NELL-1-modiﬁed BMMSCs/PLGA
group (12.2 0.65 at 6 weeks and 15.8 0.42 at 24 weeks post-
operatively, respectively n¼ 6) showed the highest score, followed
by the BMMSCs/PLGA group (7.810.45 and 12.8 0.53, respec-
tively), PLGA group (2.93 0.25 and 6.28 0.37, respectively) and
empty defect group (0.62 0.13 and 1.89 0.17, respectively). No
signiﬁcant difference was observed between the NELL-1-modiﬁed
BMMSCs/PLGA and normal groups at 24 weeks (data not shown).
At 6 weeks after operation, both the NELL-1-modiﬁed BMMSCs/
PLGA [Fig. 5(A)] and BMMSCs/PLGA [Fig. 5(B)] groups were positive
for type II collagen, but the matrix in the NELL-1-modiﬁedand BMMSCs/PLGA (B and D) groups. The matrix in the NELL-1-modiﬁed BMMSCs/PLGA
at 6 (A and B) and 24 (C and D) weeks after operation. Bar¼ 100 mm.
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BMMSCs/PLGA group. At 24 weeks after operation, type II collagen
staining was heterogeneous in regenerated cartilage of the
BMMSCs/PLGA group [Fig. 5(D)] compared to the NELL-1-modiﬁed
BMMSCs/PLGA group [Fig. 5(C)]. No positive immunostaining for
type II collagen was observed in either of the PLGA group or empty
defect groups (data not shown).m-CT examination
m-CT analysis demonstrated increasing bone formation
within defects throughout a 24-week time period for all
animals (Fig. 6, n¼ 6). At 6 weeks, the NELL-1-modiﬁed
BMMSCs/PLGA group [Fig. 6(A), 51.2% 7.1] exhibited the
highest mineralized volume fraction (BV/TV), followed by the
BMMSCs/PLGA group [Fig. 6(B), 42.4% 6.3] and PLGA group
[Fig. 6(C), 31.7% 4.1], and the empty defect group induced
minimal bone formation [Fig. 6(D), 27.2% 2.5]. At 24 weeks,
BV/TV was higher in the NELL-1-modiﬁed BMMSCs/PLGA
[Fig. 6(E), 60.7% 9.4] and BMMSCs/PLGA [Fig. 6(F), 59.1% 9.5]
groups than in the PLGA [Fig. 6(G), 50.7% 6.8] and empty
defect [Fig. 6(H), 45.6% 5.8] groups. However, no differences in
BV/TV were found between the NELL-1-modiﬁed BMMSCs/PLGA
and BMMSCs/PLGA groups.Fig. 6. Representative m-CT images of the defects at 6 (AeD) and 24 (EeH) weeks after opera
group. (C and G) PLGA group. (D and H) Empty defect group. (I) BV/TV of different groupsIn vivo tracing of implanted cells
BMMSCs transduced with Ad-NELL-1 were examined by X-gal
staining under light microscopy [Fig. 7(A)]. In the 6-week repaired
samples, blue color tissues ﬁlled within the scaffolds after X-gal
staining [Fig. 7(B)]. Histological sections from sagittal plane with
Safranin-O counterstaining also showed the presence of implanted
cells in the defect. These blue cells stayed in the newly formed
cartilage and bone [Fig. 7(C and D)].Discussion
The present study evaluated the effects of NELL-1-modiﬁed
BMMSCs/PLGA composite on repair of large osteochondral defects
in the mandibular condyle. Our results demonstrate a therapeutic
beneﬁt of BMMSCs transplantation utilizing PLGA scaffolds to
facilitate repair of osteochondral defects in themandibular condyle,
and the transfer of BMMSCs with NELL-1 gene can enhance the
observed effects, as evidenced by better cartilage surfacing and
subchondral bone formation.
Surgically created full-thickness articular cartilage defects have
been studied in rabbits to evaluate the effect of new procedures
designed to elicit articular cartilage repair. However, both the
cartilage and the bone surrounding the defect have differenttion (n¼ 6). (A and E) NELL-1-modiﬁed BMMSCs/PLGA group. (B and F) BMMSCs/PLGA
at 6 and 24 weeks. The data shown are the means 95% CI.
Fig. 7. X-gal staining for implanted cells tracing at 6 weeks after operation. (A) X-gal staining in Ad-NELL-1 transduced BMMSCs. (B) Blue color tissues ﬁlled within the defects.
(C and D) Histological section showed the blue color tissues in the defect. Safranin-O counterstaining; bars¼ 100 mm in A, and 50 mm in C and D.
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depth of the lesion aswell as on the animalmodel being used. To our
knowledge, the repair of large osteochondral defects in mandibular
condyle with tissue engineering has not been systematically
studied. In this study, the goatwas chosenbecause its TMJ resembles
that of humans and the size of goat mandibular condyle is large
enough to create a critical-sized osteochondral defect16. It has
previously been reported that a 1-mm-diameter and 10-mm-deep
defect in the sheep mandibular condyle was repaired with ﬁbro-
osseous connective tissue 3 months postoperatively17. In this study,
the 3-mm-diameter and 5-mm-deep osteochondral defects pre-
sented a more challenging repair problem in mandibular condyle
because such a defect exceeded a critical size for spontaneous repair.
Methods such as transplantation with chondrocytes18 or local
application of certain growth factors like rhBMP-219 or FGF-220 have
been used to stimulate cartilage regeneration in rabbit mandibular
condyle. In another study, it was found that a PLGA copolymer and
gelatin sponge complex with or without rhBMP-2 could induce
regeneration of new bone and cartilage-like tissue following con-
dylectomy in the rabbits21. However, few of these studies had a sus-
tained, reliable outcome. Since osteochondral injury involves damage
to both bone and cartilage, addition of BMMSCs capable of differenti-
ating into both chondrogenic and osteogenic lineages may help facili-
tate tissue regeneration. Several studieshavesuggested that combining
BMMSCs with scaffold implantation might promote osteochondral
repair in major synovial joints7,8,10. This study extends those ﬁndings
and shows that the BMMSCs/PLGA group had signiﬁcantly better
cartilage repair of critically large defects in the mandibular condyle
when compared with the goats received cell-free PLGA scaffolds.
On the other hand, cartilage repair using BMMSCsmust solve some
of the problems associated with differentiation into chondrocytes,
remodeling and organization of a new extracellular matrix to form
new cartilage tissue. Growth factors have shown promise in stimu-
lating the differentiation into chondrocytes and the maintenance oflineage to chondrogenesis in vitro and in animal models. NELL-1 is
a novel growth factor believed to speciﬁcally target cells committed to
the osteochondral lineage. However, NELL-1 is a secreted protein and
has a short half value period in vivo, which affects its bioactivity and
longevity. Therefore, controlled delivery of NELL-1 may be a possible
modality to regenerate osteochondral defects.
Recent study found that NELL-1-incorporated chitosan micro-
particles provide controlled delivery and maximize biological
efﬁciency, and promote chondrocytes proliferation and deposition
of cartilage-speciﬁc extracellular matrix materials in vitro14.
Aghaloo et al.22 reported another drug delivery systemof NELL-1, in
which Ad-NELL-1 gene was transferred into primary adult goat
bone marrow stromal cells (BMSCs) and it was found that goat
BMSCs were successfully transduced at a relatively high efﬁciency
of approximately 70% and survived at least 4 weeks after in vivo
intramuscular injection of nude mice. In the current study, we also
used autogenous BMMSCs as a vehicle to carry NELL-1 gene, and
transplanted into the osteochondral defect utilizing PLGA scaf-
folds. To our knowledge, this is the ﬁrst report to evaluate Nell-1’s
therapeutic potential for the repair of large osteochondral defects
using an ex vivo gene therapy technique. Better cartilage resur-
facing and subchondral bone formationwere observed in theNELL-
modiﬁed BMMSCs/PLGA groupwhen comparedwith the BMMSCs/
PLGA group. We thought that this controlled release method can
effectively extend the duration of bioactive NELL-1, and make
a contribution to osteochondral regeneration.
The in vivo tracing experiment conﬁrmed that these BMMSCs can
survive for at least 6 weeks in vivo, veriﬁed by either X-gal staining.
This ﬁnding is consistent with a previous study in knee joint8.
Additionally, the transplanted BMMSCs were observed both in the
regenerate cartilage and subchondral bone, suggesting that the
transplanted cells, at least in part, directly participate in cartilage
and bone regeneration. On the other hand, although the BMMSCs do
provide a practical source of autogenous cells with chondrogenic
S. Zhu et al. / Osteoarthritis and Cartilage 19 (2011) 743e750750and osteogenic potential, it is quite possible that host cells are also
involved or even dominate in the repair process. Local trans-
plantation of BMMSCs was proven to recruit more circulating stem/
progenitor cells to the region of injury and contributed to healing23.
In the present study, the transplanted BMMSCs also served to recruit
host stemcells in the subchondral bone or to stimulate replication of
chondrocytes in the recipient cartilage. It is clear that the topical
persistence of bioactive NELL-1 released from BMMSCs contributes
to and enhances these effects. However, the time period was only
extended to 24weeks. It is possible that persistence of NELL-1 in the
fully repaired defect may be detrimental beyond 24 weeks. This
limitation should be resolved in further investigations.
In conclusion, NELL-1-modiﬁed BMMSCs/PLGA can successfully
induce ﬁbrocartilage and subchondral bone within the period of 24
weeks. These ﬁndings demonstrate that this new composite would
lead to an improvement in the quality and quantity in the repair of
large osteochondral defects.
Author contributions
Dr Hu had full access to all of the data in the study and takes
responsibility for the integrity of the data and the accuracy of the
data analysis. All authors approved the ﬁnal version to be published.
Study conception and design. Hu, Zhu.
Acquisition of data. Zhu, Zhang.
Analysis and interpretation of data. Hu, Zhu, Zhang, Man.
Manuscript preparation. Zhu, Zhang, Hu.
Statistical analysis. Zhu, Ma.
Role of the funding source
The authors state that the study sponsors have no involvement
in the study design, collection, analysis and interpretation of data;
in the writing of the manuscript; and in the decision to submit the
manuscript for publication.
Competing interest statement
All authors have no ﬁnancial and personal relationships with other
people or organizations that could potentially and inappropriately
inﬂuence (bias) their work and conclusions.
Acknowledgment
This investigation was supported by the grant (No. 30700951)
fromtheCommittee ofNationalNature Science Foundation inChina.
References
1. Kuroda S, Tanimoto K, Izawa T, Fujihara S, Koolstra JH, Tanaka E.
Biomechanical and biochemical characteristics of themandibular
condylar cartilage. Osteoarthritis Cartilage 2009;17:1408e15.
2. Wu MJ, Gu ZY, Sun W. Effects of hydrostatic pressure on
cytoskeleton and BMP-2, TGF-beta, SOX-9 p.oduction in rat
temporomandibular synovial ﬁbroblasts. Osteoarthritis
Cartilage 2008;16:41e7.
3. Man C, Zhu S, Zhang B, Hu J. Protection of articular cartilage
from degeneration by injection of transforming growth factor-
beta in temporomandibular joint osteoarthritis. Oral Surg Oral
Med Oral Pathol Oral Radiol Endod 2009;108:335e40.
4. Manfredini D, Piccotti F, Guarda-Nardini L. Hyaluronic acid in
the treatment of TMJ disorders: a systematic review of the
literature. Cranio 2010;28:166e76.
5. Aktas I, Yalcin S, Sencer S. Intra-articular injection of tenox-
icam following temporomandibular joint arthrocentesis:
a pilot study. Int J Oral Maxillofac Surg 2010;39:440e5.6. Møystad A, Mork-Knutsen BB, Bjørnland T. Injection of sodium
hyaluronate compared to a corticosteroid in the treatment of
patients with temporomandibular joint osteoarthritis: a CT
evaluation. Oral Surg Oral Med Oral Pathol Oral Radiol Endod
2008;105:e53e60.
7. Frenkel SR, Bradica G, Brekke JH, Goldman SM, Ieska K,
Issack P, et al. Regeneration of articular cartilage-evaluation of
osteochondral defect repair in the rabbit using multiphasic
implants. Osteoarthritis Cartilage 2005;13:798e807.
8. Shao X, Goh JC, Hutmacher DW, Lee EH, Zigang G. Repair of
large articular osteochondral defects using hybrid scaffolds
and bone marrow-derived mesenchymal stem cells in a rabbit
model. Tissue Eng 2006;12:1539e51.
9. Alhadlaq A, Mao JJ. Tissue-engineered neogenesis of human-
shaped mandibular condyle from rat mesenchymal stem cells.
J Dent Res 2003;82:951e6.
10. Fan H, Liu H, Zhu R, Li X, Cui Y, Hu Y, et al. Comparison of
chondral defects repair with in vitro and in vivo differentiated
mesenchymal stem cells. Cell Transplant 2007;16:823e32.
11. Park JS, Yang HN, Woo DG, Chung HM, Park KH. In vitro and in
vivo chondrogenesis of rabbit bone marrow-derived stromal
cells in ﬁbrin matrix mixed with growth factor loaded in
nanoparticles. Tissue Eng Part A 2009;15:2163e75.
12. Cowan CM, Cheng S, Ting K, Soo C, Walder B, Wu B, et al. Nell-1
induced bone formation within the distracted intermaxillary
suture. Bone 2006;38:48e58.
13. Aghaloo T, Cowan CM, Chou YF, Zhang X, Lee H, Miao S, et al.
Nell-1-induced bone regeneration in calvarial defects. Am J
Pathol 2006;169:903e15.
14. Lee M, Siu RK, Ting K, Wu BM. Effect of Nell-1 delivery on
chondrocyte proliferation and cartilaginous extracellular
matrix deposition. Tissue Eng Part A 2010;16:1791e800.
15. Im GI, Kim DY, Shin JH, Hyun CW, Cho WH. Repair of cartilage
defect in the rabbit with cultured mesenchymal stem cells
from bone marrow. J Bone Joint Surg Br 2001;83:289e94.
16. Zhu SS, Hu J, Ying BB, Li JH. Growth of the mandible after
condylar reconstruction using transport distraction osteo-
genesis: an experimental investigation in goats. Plast Reconstr
Surg 2008;121:1760e7.
17. Ishimaru JI, Kurita K, Handa Y, Goss AN. Effect of marrow
perforation on the sheep temporomandibular joint. Int J Oral
Maxillofac Surg 1992;21:239e42.
18. Yao X, Ma X, Zhang Z. Chondrocyte allografts for repair of full-
thickness defects in the condylar articular cartilage of rabbits.
Chin J Dent Res 2000;3:24e30.
19. Suzuki T, Bessho K, Fujimura K, Okubo Y, Segami N, Iizuka T.
Regeneration of defects in the articular cartilage in rabbit
temporomandibular joints by bone morphogenetic protein-2.
Br J Oral Maxillofac Surg 2002;40:201e6.
20. Takafuji H, Suzuki T, Okubo Y, Fujimura K, Bessho K. Regen-
eration of articular cartilage defects in the temporomandibular
joint of rabbits by ﬁbroblast growth factor-2: a pilot study. Int J
Oral Maxillofac Surg 2007;36:934e7.
21. Ueki K, Takazakura D, Marukawa K, Shimada M, Nakagawa K,
Takatsuka S, et al. The use of polylactic acid/polyglycolic acid
copolymer and gelatin sponge complex containing human
recombinant bone morphogenetic protein-2 following con-
dylectomy in rabbits. J Craniomaxillofac Surg 2003;31:107e14.
22. Aghaloo T, Jiang X, Soo C, Zhang Z, Zhang X, Hu J, et al. A study of
the role of Nell-1 genemodiﬁed goat bonemarrow stromal cells
in promoting newbone formation.Mol Ther 2007;15:1872e80.
23. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, et al.
Local delivery of marrow-derived stromal cells augments
collateral perfusion through paracrine mechanisms. Circula-
tion 2004;109:1543e9.
